- The FDA approved the CAP for admission to its Network of Experts to provide the agency with additional expertise on a wide-range of issues pathology
WASHINGTON – The US Food and Drug Administration (FDA) approved the College of American Pathologists for admission to its Network of Experts to provide the agency with additional expertise on pathology and laboratory medicine issues, such as those concerning the COVID-19 pandemic and artificial intelligence.
The FDA Network of Experts is a vetted network of partner organizations and their member scientists, clinicians, and engineers who provide the FDA rapid access to expertise when it is needed to supplement existing knowledge and expertise within the administration’s Center for Devices and Radiological Health and the Center for Drug Evaluation and Research.
“As the world’s largest organization of board-certified pathologists, the CAP stands ready to lend its knowledge on laboratory, diagnostic testing, and all other pathology issues to the FDA,” said CAP President Patrick Godbey, MD, FCAP. “The CAP has expertise on a wide-range of issues concerning pathology. This includes those involving leading-edge and digital health care technologies. We look forward to participating as part of the Network of Experts and answering clinical questions from the FDA as they arise.”
The FDA Network of Experts Program currently partners with more than 100 professional organizations. The goal of the program is to allow FDA staff to tap into a virtual network of scientific experts after defining a scientific question that FDA staff need to address quickly
Throughout the COVID-19 pandemic, the CAP has served as a resource to the government, Congress, and the general public on diagnostic testing. For more information about the CAP’s latest work, go to cap.org.
###
About the College of American Pathologists
As the world’s largest organization of board-certified pathologists and leading provider of laboratory accreditation and proficiency testing programs, the College of American Pathologists (CAP) serves patients, pathologists, and the public by fostering and advocating excellence in the practice of pathology and laboratory medicine worldwide. As a 501(c)(6) membership organization, the CAP is the only entity representing pathologists with unrestricted advocacy capability and a political action committee, PathPAC. For more information, visit yourpathologist.org to watch pathologists at work and see the stories of the patients who trust them with their care. Read the CAP Annual Report.